Vita Life Sciences Ltd (VLS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.125x

Based on the latest financial reports, Vita Life Sciences Ltd (VLS) has a cash flow conversion efficiency ratio of 0.125x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$6.60 Million ≈ $4.67 Million USD) by net assets (AU$52.62 Million ≈ $37.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vita Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Vita Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read VLS liabilities breakdown for a breakdown of total debt and financial obligations.

Vita Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vita Life Sciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NCS Multistage Holdings Inc NASDAQ:NCSM	0.056x
Genovate Biotechnology Co Ltd TWO:4130	0.012x
Papaya Growth Opportunity Corp I NASDAQ:PPYA	0.001x
Ablerex Electronics Co Ltd TWO:3628	0.104x
Dhunseri Ventures Limited NSE:DVL	-0.046x
Pinar Sut Mamulleri Sanayi AS IS:PNSUT	0.025x
Miwon Holdings Co. Ltd KO:107590	0.012x
Bioton S.A. WAR:BIO	0.017x

Annual Cash Flow Conversion Efficiency for Vita Life Sciences Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Vita Life Sciences Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see VLS market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$52.28 Million ≈ $36.99 Million	AU$6.16 Million ≈ $4.36 Million	0.118x	-60.71%
2023-12-31	AU$43.33 Million ≈ $30.66 Million	AU$12.98 Million ≈ $9.19 Million	0.300x	+294.10%
2022-12-31	AU$36.50 Million ≈ $25.83 Million	AU$2.77 Million ≈ $1.96 Million	0.076x	-60.73%
2021-12-31	AU$30.42 Million ≈ $21.53 Million	AU$5.89 Million ≈ $4.17 Million	0.194x	-37.28%
2020-12-31	AU$24.44 Million ≈ $17.29 Million	AU$7.54 Million ≈ $5.34 Million	0.309x	+242.94%
2019-12-31	AU$22.53 Million ≈ $15.94 Million	AU$2.03 Million ≈ $1.43 Million	0.090x	-29.04%
2018-12-31	AU$22.41 Million ≈ $15.85 Million	AU$2.84 Million ≈ $2.01 Million	0.127x	-2.28%
2017-12-31	AU$24.79 Million ≈ $17.54 Million	AU$3.22 Million ≈ $2.28 Million	0.130x	-36.14%
2016-12-31	AU$23.18 Million ≈ $16.40 Million	AU$4.71 Million ≈ $3.33 Million	0.203x	-5.56%
2015-12-31	AU$22.88 Million ≈ $16.19 Million	AU$4.92 Million ≈ $3.48 Million	0.215x	-24.11%
2014-12-31	AU$21.57 Million ≈ $15.26 Million	AU$6.12 Million ≈ $4.33 Million	0.284x	-4.59%
2013-12-31	AU$16.27 Million ≈ $11.51 Million	AU$4.83 Million ≈ $3.42 Million	0.297x	+143.73%
2012-12-31	AU$11.34 Million ≈ $8.03 Million	AU$1.38 Million ≈ $978.56K	0.122x	-80.71%
2011-12-31	AU$8.96 Million ≈ $6.34 Million	AU$5.66 Million ≈ $4.01 Million	0.632x	+712.81%
2010-12-31	AU$8.13 Million ≈ $5.75 Million	AU$-838.65K ≈ $-593.40K	-0.103x	+83.17%
2009-12-31	AU$3.90 Million ≈ $2.76 Million	AU$-2.39 Million ≈ $-1.69 Million	-0.613x	-515.31%
2008-12-31	AU$3.85 Million ≈ $2.72 Million	AU$567.42K ≈ $401.48K	0.148x	-43.35%
2007-12-31	AU$2.88 Million ≈ $2.04 Million	AU$750.00K ≈ $530.67K	0.260x	+68.96%
2006-12-31	AU$3.35 Million ≈ $2.37 Million	AU$516.00K ≈ $365.10K	0.154x	--

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$98.16 Million

AU$138.74 Million AUD

Market Cap Rank

#19259 Global

#630 in Australia

Share Price

AU$2.54

Change (1 day)

-0.39%

52-Week Range

AU$1.76 - AU$2.83

All Time High

AU$2.83